APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biochemical Screening Test

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biochemical Screening Test Market Analysis and Forecast 2026-2032

5 July 2026176 pages

Choose your research edition.

Industry ResearchBiochemical Screening Test Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Biochemical Screening Test Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biochemical Screening Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biochemical Screening Test Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Biochemical Screening Test Market Analysis and Forecast 2026-2032176 pages · $4,950 USD

Market perspective

The global Biochemical Screening Test market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biochemical Screening Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biochemical Screening Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biochemical Screening Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biochemical Screening Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biochemical Screening Test include Yourgene Health, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc and BGI, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biochemical Screening Test, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biochemical Screening Test, also provides the revenue of main regions and countries. Of the upcoming market potential for Biochemical Screening Test, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biochemical Screening Test revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biochemical Screening Test market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biochemical Screening Test revenue, projected growth trends, production technology, application and end-user industry.

Biochemical Screening Test Segment by Company

Yourgene Health

Illumina Inc

Agilent Technologies Inc

Thermo Fisher Scientific Inc

Hoffmann-La Roche Ltd

Laboratory Corporation of America Holdings

GE Healthcare

PerkinElmer Inc

BGI

Natera Inc

Biochemical Screening Test Segment by Type

Combined First Trimester Screening

Second Trimester Maternal Serum Screening

Biochemical Screening Test Segment by Application

Diagnostic Laboratories

Hospitals

Biochemical Screening Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biochemical Screening Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biochemical Screening Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biochemical Screening Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biochemical Screening Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biochemical Screening Test company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biochemical Screening Test revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biochemical Screening Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Combined First Trimester Screening Major Player Table 3. Second Trimester Maternal Serum Screening Major Player Table 4. Global Biochemical Screening Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Diagnostic Laboratories Major Player Table 6. Hospitals Major Player Table 7. Biochemical Screening Test Industry Trends Table 8. Biochemical Screening Test Industry Drivers Table 9. Biochemical Screening Test Industry Opportunities and Challenges Table 10. Biochemical Screening Test Industry Restraints Table 11. Global Biochemical Screening Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Biochemical Screening Test Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Biochemical Screening Test Market Share by Region (2021-2026) Table 14. Global Biochemical Screening Test Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Biochemical Screening Test Market Share by Region (2027-2032) Table 16. Global Biochemical Screening Test Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Biochemical Screening Test Revenue Market Share by Players (2021-2026) Table 18. Global Biochemical Screening Test Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Biochemical Screening Test Key Players Headquarters & Area Served Table 20. Global Biochemical Screening Test Players, Product Type & Application Table 21. Global Biochemical Screening Test Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Biochemical Screening Test by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Biochemical Screening Test Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Biochemical Screening Test Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Biochemical Screening Test Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Biochemical Screening Test Revenue Market Share by Type (2021-2026) Table 28. Global Biochemical Screening Test Revenue Market Share by Type (2027-2032) Table 29. Global Biochemical Screening Test Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Biochemical Screening Test Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Biochemical Screening Test Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Biochemical Screening Test Revenue Market Share by Application (2021-2026) Table 33. Global Biochemical Screening Test Revenue Market Share by Application (2027-2032) Table 34. Yourgene Health Company Information Table 35. Yourgene Health Business Overview Table 36. Yourgene Health Biochemical Screening Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Yourgene Health Biochemical Screening Test Product Portfolio Table 38. Yourgene Health Recent Development Table 39. Illumina Inc Company Information Table 40. Illumina Inc Business Overview Table 41. Illumina Inc Biochemical Screening Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Illumina Inc Biochemical Screening Test Product Portfolio Table 43. Illumina Inc Recent Development Table 44. Agilent Technologies Inc Company Information Table 45. Agilent Technologies Inc Business Overview Table 46. Agilent Technologies Inc Biochemical Screening Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Agilent Technologies Inc Biochemical Screening Test Product Portfolio Table 48. Agilent Technologies Inc Recent Development Table 49. Thermo Fisher Scientific Inc Company Information Table 50. Thermo Fisher Scientific Inc Business Overview Table 51. Thermo Fisher Scientific Inc Biochemical Screening Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Thermo Fisher Scientific Inc Biochemical Screening Test Product Portfolio Table 53. Thermo Fisher Scientific Inc Recent Development Table 54. Hoffmann-La Roche Ltd Company Information Table 55. Hoffmann-La Roche Ltd Business Overview Table 56. Hoffmann-La Roche Ltd Biochemical Screening Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Hoffmann-La Roche Ltd Biochemical Screening Test Product Portfolio Table 58. Hoffmann-La Roche Ltd Recent Development Table 59. Laboratory Corporation of America Holdings Company Information Table 60. Laboratory Corporation of America Holdings Business Overview Table 61. Laboratory Corporation of America Holdings Biochemical Screening Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Laboratory Corporation of America Holdings Biochemical Screening Test Product Portfolio Table 63. Laboratory Corporation of America Holdings Recent Development Table 64. GE Healthcare Company Information Table 65. GE Healthcare Business Overview Table 66. GE Healthcare Biochemical Screening Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. GE Healthcare Biochemical Screening Test Product Portfolio Table 68. GE Healthcare Recent Development Table 69. PerkinElmer Inc Company Information Table 70. PerkinElmer Inc Business Overview Table 71. PerkinElmer Inc Biochemical Screening Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. PerkinElmer Inc Biochemical Screening Test Product Portfolio Table 73. PerkinElmer Inc Recent Development Table 74. BGI Company Information Table 75. BGI Business Overview Table 76. BGI Biochemical Screening Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. BGI Biochemical Screening Test Product Portfolio Table 78. BGI Recent Development Table 79. Natera Inc Company Information Table 80. Natera Inc Business Overview Table 81. Natera Inc Biochemical Screening Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Natera Inc Biochemical Screening Test Product Portfolio Table 83. Natera Inc Recent Development Table 84. North America Biochemical Screening Test Revenue by Type (2021-2026) & (US$ Million) Table 85. North America Biochemical Screening Test Revenue by Type (2027-2032) & (US$ Million) Table 86. North America Biochemical Screening Test Revenue by Application (2021-2026) & (US$ Million) Table 87. North America Biochemical Screening Test Revenue by Application (2027-2032) & (US$ Million) Table 88. North America Biochemical Screening Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Biochemical Screening Test Revenue by Country (2021-2026) & (US$ Million) Table 90. North America Biochemical Screening Test Revenue by Country (US$ Million) & (2027-2032) Table 91. Europe Biochemical Screening Test Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Biochemical Screening Test Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Biochemical Screening Test Revenue by Application (2021-2026) & (US$ Million) Table 94. Europe Biochemical Screening Test Revenue by Application (2027-2032) & (US$ Million) Table 95. Europe Biochemical Screening Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Biochemical Screening Test Revenue by Country (2021-2026) & (US$ Million) Table 97. Europe Biochemical Screening Test Revenue by Country (US$ Million) & (2027-2032) Table 98. China Biochemical Screening Test Revenue by Type (2021-2026) & (US$ Million) Table 99. China Biochemical Screening Test Revenue by Type (2027-2032) & (US$ Million) Table 100. China Biochemical Screening Test Revenue by Application (2021-2026) & (US$ Million) Table 101. China Biochemical Screening Test Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Biochemical Screening Test Revenue by Type (2021-2026) & (US$ Million) Table 103. Asia Biochemical Screening Test Revenue by Type (2027-2032) & (US$ Million) Table 104. Asia Biochemical Screening Test Revenue by Application (2021-2026) & (US$ Million) Table 105. Asia Biochemical Screening Test Revenue by Application (2027-2032) & (US$ Million) Table 106. Asia Biochemical Screening Test Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Asia Biochemical Screening Test Revenue by Region (US$ Million) & (2021-2026) Table 108. Asia Biochemical Screening Test Revenue by Region (US$ Million) & (2027-2032) Table 109. SAMEA Biochemical Screening Test Revenue by Type (2021-2026) & (US$ Million) Table 110. SAMEA Biochemical Screening Test Revenue by Type (2027-2032) & (US$ Million) Table 111. SAMEA Biochemical Screening Test Revenue by Application (2021-2026) & (US$ Million) Table 112. SAMEA Biochemical Screening Test Revenue by Application (2027-2032) & (US$ Million) Table 113. SAMEA Biochemical Screening Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. SAMEA Biochemical Screening Test Revenue by Country (2021-2026) & (US$ Million) Table 115. SAMEA Biochemical Screening Test Revenue by Country (US$ Million) & (2027-2032) Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Biochemical Screening Test Image Figure 2. Global Biochemical Screening Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biochemical Screening Test Market Size Share 2021 VS 2025 VS 2032 Figure 4. Combined First Trimester Screening Image Figure 5. Second Trimester Maternal Serum Screening Image Figure 6. Global Biochemical Screening Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Biochemical Screening Test Market Size Share 2021 VS 2025 VS 2032 Figure 8. Diagnostic Laboratories Image Figure 9. Hospitals Image Figure 10. Global Biochemical Screening Test Market Size (US$ Million) & (2021-2032) Figure 11. Global Biochemical Screening Test Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Biochemical Screening Test Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Biochemical Screening Test Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Biochemical Screening Test Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Biochemical Screening Test Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Biochemical Screening Test Revenue Market Share by Type (2021-2032) Figure 18. Global Biochemical Screening Test Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Biochemical Screening Test Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Biochemical Screening Test Revenue Market Share by Application (2021-2032) Figure 21. North America Biochemical Screening Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Biochemical Screening Test Revenue Share by Type (2021-2032) Figure 23. North America Biochemical Screening Test Revenue Share by Application (2021-2032) Figure 24. North America Biochemical Screening Test Revenue Share by Country (2021-2032) Figure 25. United States Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Biochemical Screening Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Biochemical Screening Test Revenue Share by Type (2021-2032) Figure 30. Europe Biochemical Screening Test Revenue Share by Application (2021-2032) Figure 31. Europe Biochemical Screening Test Revenue Share by Country (2021-2032) Figure 32. Germany Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Biochemical Screening Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Biochemical Screening Test Revenue Share by Type (2021-2032) Figure 42. China Biochemical Screening Test Revenue Share by Application (2021-2032) Figure 43. Asia Biochemical Screening Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Biochemical Screening Test Revenue Share by Type (2021-2032) Figure 45. Asia Biochemical Screening Test Revenue Share by Application (2021-2032) Figure 46. Asia Biochemical Screening Test Revenue Share by Region (2021-2032) Figure 47. Japan Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Biochemical Screening Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Biochemical Screening Test Revenue Share by Type (2021-2032) Figure 55. SAMEA Biochemical Screening Test Revenue Share by Application (2021-2032) Figure 56. SAMEA Biochemical Screening Test Revenue Share by Country (2021-2032) Figure 57. Brazil Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Biochemical Screening Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Combined First Trimester Screening
  • Second Trimester Maternal Serum Screening
Applications
  • Diagnostic Laboratories
  • Hospitals
Companies covered
  • Yourgene Health
  • Illumina Inc
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • Hoffmann-La Roche Ltd
  • Laboratory Corporation of America Holdings
  • GE Healthcare
  • PerkinElmer Inc
  • BGI
  • Natera Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biochemical Screening Test Market by Type
  3. 1.2.1 Global Biochemical Screening Test Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Combined First Trimester Screening
  5. 1.2.3 Second Trimester Maternal Serum Screening
  6. 1.3 Biochemical Screening Test Market by Application
  7. 1.3.1 Global Biochemical Screening Test Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Diagnostic Laboratories
  9. 1.3.3 Hospitals
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Biochemical Screening Test Market Dynamics
  1. 2.1 Biochemical Screening Test Industry Trends
  2. 2.2 Biochemical Screening Test Industry Drivers
  3. 2.3 Biochemical Screening Test Industry Opportunities and Challenges
  4. 2.4 Biochemical Screening Test Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biochemical Screening Test Market Perspective (2021-2032)
  2. 3.2 Global Biochemical Screening Test Growth Trends by Region
  3. 3.2.1 Global Biochemical Screening Test Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biochemical Screening Test Market Size by Region (2021-2026)
  5. 3.2.3 Global Biochemical Screening Test Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biochemical Screening Test Revenue by Players
  2. 4.1.1 Global Biochemical Screening Test Revenue by Players (2021-2026)
  3. 4.1.2 Global Biochemical Screening Test Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biochemical Screening Test Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biochemical Screening Test Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biochemical Screening Test Key Players Headquarters & Area Served
  7. 4.4 Global Biochemical Screening Test Players, Product Type & Application
  8. 4.5 Global Biochemical Screening Test Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biochemical Screening Test Market CR5 and HHI
  11. 4.6.3 2025 Biochemical Screening Test Tier 1, Tier 2, and Tier 3
5 Biochemical Screening Test Market Size by Type
  1. 5.1 Global Biochemical Screening Test Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biochemical Screening Test Revenue by Type (2021-2032)
  3. 5.3 Global Biochemical Screening Test Revenue Market Share by Type (2021-2032)
6 Biochemical Screening Test Market Size by Application
  1. 6.1 Global Biochemical Screening Test Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biochemical Screening Test Revenue by Application (2021-2032)
  3. 6.3 Global Biochemical Screening Test Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Yourgene Health
  2. 7.1.1 Yourgene Health Company Information
  3. 7.1.2 Yourgene Health Business Overview
  4. 7.1.3 Yourgene Health Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Yourgene Health Biochemical Screening Test Product Portfolio
  6. 7.1.5 Yourgene Health Recent Developments
  7. 7.2 Illumina Inc
  8. 7.2.1 Illumina Inc Company Information
  9. 7.2.2 Illumina Inc Business Overview
  10. 7.2.3 Illumina Inc Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Illumina Inc Biochemical Screening Test Product Portfolio
  12. 7.2.5 Illumina Inc Recent Developments
  13. 7.3 Agilent Technologies Inc
  14. 7.3.1 Agilent Technologies Inc Company Information
  15. 7.3.2 Agilent Technologies Inc Business Overview
  16. 7.3.3 Agilent Technologies Inc Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Agilent Technologies Inc Biochemical Screening Test Product Portfolio
  18. 7.3.5 Agilent Technologies Inc Recent Developments
  19. 7.4 Thermo Fisher Scientific Inc
  20. 7.4.1 Thermo Fisher Scientific Inc Company Information
  21. 7.4.2 Thermo Fisher Scientific Inc Business Overview
  22. 7.4.3 Thermo Fisher Scientific Inc Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Thermo Fisher Scientific Inc Biochemical Screening Test Product Portfolio
  24. 7.4.5 Thermo Fisher Scientific Inc Recent Developments
  25. 7.5 Hoffmann-La Roche Ltd
  26. 7.5.1 Hoffmann-La Roche Ltd Company Information
  27. 7.5.2 Hoffmann-La Roche Ltd Business Overview
  28. 7.5.3 Hoffmann-La Roche Ltd Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Hoffmann-La Roche Ltd Biochemical Screening Test Product Portfolio
  30. 7.5.5 Hoffmann-La Roche Ltd Recent Developments
  31. 7.6 Laboratory Corporation of America Holdings
  32. 7.6.1 Laboratory Corporation of America Holdings Company Information
  33. 7.6.2 Laboratory Corporation of America Holdings Business Overview
  34. 7.6.3 Laboratory Corporation of America Holdings Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Laboratory Corporation of America Holdings Biochemical Screening Test Product Portfolio
  36. 7.6.5 Laboratory Corporation of America Holdings Recent Developments
  37. 7.7 GE Healthcare
  38. 7.7.1 GE Healthcare Company Information
  39. 7.7.2 GE Healthcare Business Overview
  40. 7.7.3 GE Healthcare Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GE Healthcare Biochemical Screening Test Product Portfolio
  42. 7.7.5 GE Healthcare Recent Developments
  43. 7.8 PerkinElmer Inc
  44. 7.8.1 PerkinElmer Inc Company Information
  45. 7.8.2 PerkinElmer Inc Business Overview
  46. 7.8.3 PerkinElmer Inc Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  47. 7.8.4 PerkinElmer Inc Biochemical Screening Test Product Portfolio
  48. 7.8.5 PerkinElmer Inc Recent Developments
  49. 7.9 BGI
  50. 7.9.1 BGI Company Information
  51. 7.9.2 BGI Business Overview
  52. 7.9.3 BGI Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BGI Biochemical Screening Test Product Portfolio
  54. 7.9.5 BGI Recent Developments
  55. 7.10 Natera Inc
  56. 7.10.1 Natera Inc Company Information
  57. 7.10.2 Natera Inc Business Overview
  58. 7.10.3 Natera Inc Biochemical Screening Test Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Natera Inc Biochemical Screening Test Product Portfolio
  60. 7.10.5 Natera Inc Recent Developments
8 North America
  1. 8.1 North America Biochemical Screening Test Revenue (2021-2032)
  2. 8.2 North America Biochemical Screening Test Revenue by Type (2021-2032)
  3. 8.2.1 North America Biochemical Screening Test Revenue by Type (2021-2026)
  4. 8.2.2 North America Biochemical Screening Test Revenue by Type (2027-2032)
  5. 8.3 North America Biochemical Screening Test Revenue Share by Type (2021-2032)
  6. 8.4 North America Biochemical Screening Test Revenue by Application (2021-2032)
  7. 8.4.1 North America Biochemical Screening Test Revenue by Application (2021-2026)
  8. 8.4.2 North America Biochemical Screening Test Revenue by Application (2027-2032)
  9. 8.5 North America Biochemical Screening Test Revenue Share by Application (2021-2032)
  10. 8.6 North America Biochemical Screening Test Revenue by Country
  11. 8.6.1 North America Biochemical Screening Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biochemical Screening Test Revenue by Country (2021-2026)
  13. 8.6.3 North America Biochemical Screening Test Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biochemical Screening Test Revenue (2021-2032)
  2. 9.2 Europe Biochemical Screening Test Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biochemical Screening Test Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biochemical Screening Test Revenue by Type (2027-2032)
  5. 9.3 Europe Biochemical Screening Test Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biochemical Screening Test Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biochemical Screening Test Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biochemical Screening Test Revenue by Application (2027-2032)
  9. 9.5 Europe Biochemical Screening Test Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biochemical Screening Test Revenue by Country
  11. 9.6.1 Europe Biochemical Screening Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biochemical Screening Test Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biochemical Screening Test Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biochemical Screening Test Revenue (2021-2032)
  2. 10.2 China Biochemical Screening Test Revenue by Type (2021-2032)
  3. 10.2.1 China Biochemical Screening Test Revenue by Type (2021-2026)
  4. 10.2.2 China Biochemical Screening Test Revenue by Type (2027-2032)
  5. 10.3 China Biochemical Screening Test Revenue Share by Type (2021-2032)
  6. 10.4 China Biochemical Screening Test Revenue by Application (2021-2032)
  7. 10.4.1 China Biochemical Screening Test Revenue by Application (2021-2026)
  8. 10.4.2 China Biochemical Screening Test Revenue by Application (2027-2032)
  9. 10.5 China Biochemical Screening Test Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biochemical Screening Test Revenue (2021-2032)
  2. 11.2 Asia Biochemical Screening Test Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biochemical Screening Test Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biochemical Screening Test Revenue by Type (2027-2032)
  5. 11.3 Asia Biochemical Screening Test Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biochemical Screening Test Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biochemical Screening Test Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biochemical Screening Test Revenue by Application (2027-2032)
  9. 11.5 Asia Biochemical Screening Test Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biochemical Screening Test Revenue by Country
  11. 11.6.1 Asia Biochemical Screening Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biochemical Screening Test Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biochemical Screening Test Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biochemical Screening Test Revenue (2021-2032)
  2. 12.2 SAMEA Biochemical Screening Test Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biochemical Screening Test Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biochemical Screening Test Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biochemical Screening Test Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biochemical Screening Test Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biochemical Screening Test Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biochemical Screening Test Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biochemical Screening Test Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biochemical Screening Test Revenue by Country
  11. 12.6.1 SAMEA Biochemical Screening Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biochemical Screening Test Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biochemical Screening Test Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst